Skip to content

Contribution of Auriculotherapy in the Management of Mastectomy With Immediate Reconstruction by Latissimus Dorsi Flap (ATMAGD)

Contribution of Auriculotherapy in the Management of Mastectomy With Immediate Reconstruction by Latissimus Dorsi Flap (ATMAGD)

Status
Terminated
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05126615
Acronym
ATMAGD
Enrollment
10
Registered
2021-11-19
Start date
2019-05-10
Completion date
2021-09-17
Last updated
2026-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Auriculotherapy, Mastectomy

Brief summary

Over the past decade, more and more healthcare professionals are using auriculotherapy as a preventative and effective therapy for pain. This therapy is applied by odontologists, anesthetists, surgeons, etc., to alleviate chronic pain. The effects of auriculotherapy are known in particular in reducing preoperative anxiety, pain in cancer patients and postoperative pain. The aim of this study is to assess the effectiveness of adding auriculotherapy to the standard global anesthetic protocol, compared to this single reference protocol, on the incidence at 3 months post-intervention of Chronic Post-Surgical Pain, in patients operated for a mastectomy with reconstruction immediate by latissimus dorsi flap.

Interventions

Application of a bolus of 5 μ of liquid nitrogen via a cryospray on the auriculotherapy points A4, C18, D9, C9, DIX, H13, G14 and FXVII, chosen according to a neurophysiological reasoning taking into account the surgical intervention performed and innervation of the anatomical region affected by the intervention.

BEHAVIORALChronic Post-Surgical Pain evaluation

Different questionnaires : BPI : Brief Pain Inventory DN4

Sponsors

GCS Ramsay Santé pour l'Enseignement et la Recherche
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Women patient over 18 years-old * Patient scheduled for a mastectomy with immediate reconstruction by latissimus dorsi flap with or without symmetrization on the contralateral breast. * Patient affiliated or beneficiary of a social security scheme. * Patient who has given her free and informed consent. * Preoperative blood test showing no contraindication to the operation.

Exclusion criteria

* Refusal of the patient. * No indication for auriculotherapy: * Patient having a heavy treatment with neuroleptics, * Or tricyclic antidepressants which interfere with the action of auriculotherapy. * Patient undergoing long-term morphine treatment for chronic pain. * Patient with unweaned opioid addiction. * Chronic painful patient. * Protected patient: Major under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision; Hospitalized without consent. * Pregnant, breastfeeding or parturient woman. * Patient participating in another interventional study. * Patient who had already participated in this study as part of first breast surgery. * Patient receiving regular care by auriculotherapy

Design outcomes

Primary

MeasureTime frameDescription
Presence, or not, of Chronic Post-Surgical Pain (DCPC)3 monthsDCPC noted during the clinical examination of the 3rd postoperative month : \- score obtained at BPI : Brief Pain Inventory (9 items : many items with answers between 0 and 10)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 17, 2026